Analysis of proteins recovered in the S100 precipitate fraction of Streptomyces griseus after ultracentrifugation led to the identification of a 52-kDa protein which is produced during the late growth phase. The gene (eshA) which codes for this protein was cloned from S. griseus, and then its homologue was cloned from Streptomyces coelicolor A3(2). The protein was deduced to be 471 amino acids in length. The protein EshA is characterized by a central region that shows homology to the eukaryotic-type cyclic nucleotide-binding domains. Significant homology was also found to MMPI in Mycobacterium leprae, a major antigenic protein to humans. The eshA gene mapped near the chromosome end and was not essential for viability, as demonstrated by gene disruption experiments, but its disruption resulted in the abolishment of an antibiotic (actinorhodin but not undecylprodigiosin) production. Aerial mycelium was produced as abundantly as by the parent strain. Expression analysis of the EshA protein by Western blotting revealed that EshA is present only in late-growthphase cells. The eshA gene was transcribed just preceding intracellular accumulation of the EshA protein, as determined by S1 nuclease protection, indicating that EshA expression is regulated at the transcription level. The expression of EshA was unaffected by introduction of the relA mutation, which blocks ppGpp synthesis.Streptomycetes are gram-positive filamentous soil bacteria which produce a wide variety of secondary metabolites that include about half of the known microbial antibiotics. In addition to antibiotic production (physiological differentiation), the genus Streptomyces is also characterized by the ability to form aerial mycelium from vegetative mycelium when grown in solid culture (morphological differentiation). Streptomyces coelicolor A3(2), the most fully genetically characterized streptomycete, is an appropriate strain for studying the regulation of morphological and physiological differentiation (for a review, see the work by Chater and Hopwood [2]). This strain produces at least four antibiotics, of which the blue-pigmented polyketide antibiotic actinorhodin and the red-pigmented antibiotic undecylprodigiosin are usually produced in stationaryphase cultures (reviewed by Chater and Bibb [3]). Much progress has been made in elucidating not only the organization of antibiotic biosynthesis gene clusters in several Streptomyces species but also a number of pathway-specific regulatory genes that are required for the activation of their cognate biosynthesis genes (reviewed by Hunter and Baumberg [7]). In addition to pathway-specific regulatory genes, S. coelicolor possesses several genes that have pleiotropic effects on antibiotic production. These genes fall into two classes: those that affect only antibiotic production (absA, absB, afsB, afsR, and abaA) and those that affect both antibiotic production and morphological differentiation (bldA, bldB, bldC, bldD, bldF, bldG, bldH, bldI, bldJ, bldK, bldL, bldM, and bldN) (for reviews, see reference...